Researcher
Gilles Defraene
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2010 → Today
Projects
1 - 3 of 3
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → 30 Sep 2023Funding: FWO junior postdoctoral fellowship
- Image-based quantification of radiation-induced lung damageFrom1 Oct 2013 → 19 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 54
- Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer(2024)
Authors: Pieter Populaire, Philippe Nafteux, Gilles Defraene, Karin Haustermans
- Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer(2023)
Authors: Pieter Populaire, Gilles Defraene, Philippe Nafteux, Lieven Depypere, Johnny Moons, Karin Haustermans
Pages: 1488 - 1495 - NTCP modelling with dosiomics features for postoperative complications in oesophageal cancer(2023)
Authors: Gilles Defraene, Pieter Populaire, Edmond Sterpin, Karin Haustermans
Pages: S1869 - S1870 - The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study(2022)
Authors: Gilles Defraene, Maarten Lambrecht
Pages: 127 - 137 - Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer(2022)
Authors: Pieter Populaire, Gilles Defraene, Karin Haustermans, Edmond Sterpin
Pages: 101 - 107 - Low-dose CT allows for accurate proton therapy dose calculation and plan optimization(2022)
Authors: Masoud ElhamiAsl, Gilles Defraene, Maarten Lambrecht, Edmond Sterpin, Johan Nuyts
- Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres(2022)
Authors: Gilles Defraene, Karin Haustermans
Pages: 32 - 41 - Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)(2022)
Authors: Gilles Defraene, Maarten Lambrecht
Pages: 228 - 241 - Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability(2021)
Authors: Cédric Draulans, Raymond Oyen, Sofie Isebaert, Frederik Maes, Steven Joniau, Robin De Roover, Gilles Defraene, Karolien Goffin, Karin Haustermans
Pages: 202 - 211 - Deep learning dose prediction for IMRT of esophageal cancer: The effect of data quality and quantity on model performance(2021)
Authors: Gilles Defraene, Steven Michiels, Karin Haustermans, Edmond Sterpin
Pages: 52 - 63